📣 VC round data is live. Check it out!

Advanced Medical Solutions Group Valuation Multiples

Discover Advanced Medical Solutions Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Synektik, SI-BONE, Sunmax Biotechnology, CeriBell and more.

Advanced Medical Solutions Group Overview

About Advanced Medical Solutions Group

Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue.


Founded

1993

HQ

United Kingdom

Employees

1.6K

Financials (LTM)

Revenue: $316M
EBITDA: $70M

EV

$721M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Advanced Medical Solutions Group Financials

Advanced Medical Solutions Group reported last 12-month revenue of $316M and EBITDA of $70M.

In the same LTM period, Advanced Medical Solutions Group generated $169M in gross profit, $70M in EBITDA, and $33M in net income.

Revenue (LTM)


Advanced Medical Solutions Group P&L

In the most recent fiscal year, Advanced Medical Solutions Group reported revenue of $308M and EBITDA of $66M.

Advanced Medical Solutions Group is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 22%, and net margin of 11%.

See analyst estimates for Advanced Medical Solutions Group
LTMLast FY202320242025202620272028
Revenue$316M$308M$170M$239M$308M
Gross Profit$169M$164M$94M$125M$164M
Gross Margin53%53%56%52%53%
EBITDA$70M$66M$44M$40M$59M
EBITDA Margin22%22%26%17%19%
EBIT Margin15%15%15%12%12%
Net Profit$33M$34M$21M$10M$13M
Net Margin10%11%13%4%4%
Net Debt-$68M---

Financial data powered by Morningstar, Inc.

Advanced Medical Solutions Group Stock Performance

Advanced Medical Solutions Group has current market cap of $636M, and enterprise value of $721M.

Market Cap Evolution


Advanced Medical Solutions Group's stock price is $2.93.

Advanced Medical Solutions Group share price decreased by 0.6% in the last 30 days, and increased by 1.0% in the last year.

Advanced Medical Solutions Group has an EPS (earnings per share) of $0.16.

See more trading valuation data for Advanced Medical Solutions Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$721M$636M-0.6%-0.6%12.3%1.0%$0.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Advanced Medical Solutions Group Valuation Multiples

Advanced Medical Solutions Group trades at 2.3x EV/Revenue multiple, and 10.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Advanced Medical Solutions Group

EV / Revenue (LTM)


Advanced Medical Solutions Group Financial Valuation Multiples

As of June 4, 2026, Advanced Medical Solutions Group has market cap of $636M and EV of $721M.

Advanced Medical Solutions Group has a P/E ratio of 19.2x.

LTMLast FY202320242025202620272028
EV/Revenue2.3x2.3x4.2x3.0x2.3x
EV/EBITDA10.3x10.9x16.6x18.2x12.2x
EV/EBIT14.9x15.7x28.4x24.2x18.8x
EV/Gross Profit4.3x4.4x7.6x5.8x4.4x
P/E19.2x18.5x29.7x66.6x47.5x
EV/FCF31.7x26.8x214.7x49.9x26.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Advanced Medical Solutions Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Advanced Medical Solutions Group Margins & Growth Rates

Advanced Medical Solutions Group grew revenue by 7% and EBITDA by 12% in the last fiscal year.

In the most recent fiscal year, Advanced Medical Solutions Group reported gross margin of 53%, EBITDA margin of 22%, and net margin of 11%.

See estimated margins and future growth rates for Advanced Medical Solutions Group

Advanced Medical Solutions Group Margins

Last FY202420252026202720282029
Gross Margin53%52%53%54%
EBITDA Margin22%17%19%22%
EBIT Margin15%12%12%16%
Net Margin11%4%4%9%
FCF Margin9%6%9%8%

Advanced Medical Solutions Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%41%29%7%
Gross Profit Growth9%32%32%9%
EBITDA Growth12%(9%)49%25%
EBIT Growth12%17%29%34%
Net Profit Growth(9%)(55%)40%134%
FCF Growth(2%)330%86%(2%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Advanced Medical Solutions Group Operational KPIs

Advanced Medical Solutions Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Advanced Medical Solutions Group's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Advanced Medical Solutions Group's Rule of X is 41% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Advanced Medical Solutions Group
LTMLast FY202320242025202620272028
Rule of 4030%30%---
Bessemer Rule of X42%41%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue1%2%1%1%2%
G&A Expenses to Revenue33%40%40%39%40%
R&D Expenses to Revenue4%3%--3%
Opex to Revenue-41%41%40%41%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Advanced Medical Solutions Group Competitors

Advanced Medical Solutions Group competitors include Synektik, SI-BONE, Sunmax Biotechnology, CeriBell, BrainsWay, SD Biosensor, Mesa Laboratories, Lumibird, Nanosonics and Beta Bionics.

Most Advanced Medical Solutions Group public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Synektik2.8x2.5x11.3x9.8x
SI-BONE2.6x2.4x58.3x51.0x
Sunmax Biotechnology9.8x-17.7x-
CeriBell6.1x5.5x(10.9x)(10.2x)
BrainsWay10.3x9.2x55.0x57.3x
SD Biosensor1.0x-(1.0x)-
Mesa Laboratories3.1x3.0x17.5x11.6x
Lumibird2.9x2.9x15.0x13.9x

This data is available for Pro users. Sign up to see all Advanced Medical Solutions Group competitors and their valuation data.

Start Free Trial

Acquisitions by Advanced Medical Solutions Group

Advanced Medical Solutions Group has acquired 3 companies to date.

Last acquisition by Advanced Medical Solutions Group was on March 13th 2024. Advanced Medical Solutions Group acquired Péters Surgical for $154M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Advanced Medical Solutions Group

Péters Surgical
Raleigh Coatings
Sealantis
Description
Péters Surgical is a Bobigny, France-based developer and manufacturer of single-use surgical devices. The company produces sutures, haemostatic clips, vascular occlusion tools, laparoscopic instruments, and surgical glues for operating rooms worldwide. As the only French suture producer and European leader in haemostatic clips, it supplies hospitals in over 90 countries.
Raleigh Coatings is a coater and converter serving wound care and bio-diagnostics sectors. It handles lab-scale to large production runs of specialty materials through raleighcoatings.com.
Sealantis is a Haifa-based biotechnology company developing alginate-derived tissue adhesives for surgical applications. Its platform technology mimics algal polymers to create sealants for hemostasis, leakage prevention, and drug delivery in cardiovascular, gastrointestinal, and ophthalmic procedures. Products include adhesives for wound closure and anti-adhesion barriers tested in preclinical models. Sealantis collaborates with medical device firms for commercialization in minimally invasive surgeries.
HQ CountryFranceUnited KingdomIsrael
HQ City
Paris
Stafford
Haifa
Deal Date13 Mar 202423 Nov 202031 Jan 2019
Valuation$154M$28M$25M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Advanced Medical Solutions Group acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Advanced Medical Solutions Group

When was Advanced Medical Solutions Group founded?Advanced Medical Solutions Group was founded in 1993.
Where is Advanced Medical Solutions Group headquartered?Advanced Medical Solutions Group is headquartered in United Kingdom.
How many employees does Advanced Medical Solutions Group have?As of today, Advanced Medical Solutions Group has over 1K employees.
Who is the CEO of Advanced Medical Solutions Group?Advanced Medical Solutions Group's CEO is Christopher Andrew Meredith.
Is Advanced Medical Solutions Group publicly listed?Yes, Advanced Medical Solutions Group is a public company listed on London Stock Exchange.
What is the stock symbol of Advanced Medical Solutions Group?Advanced Medical Solutions Group trades under AMS ticker.
When did Advanced Medical Solutions Group go public?Advanced Medical Solutions Group went public in 2002.
Who are competitors of Advanced Medical Solutions Group?Advanced Medical Solutions Group main competitors include Synektik, SI-BONE, Sunmax Biotechnology, CeriBell, BrainsWay, SD Biosensor, Mesa Laboratories, Lumibird, Nanosonics, Beta Bionics.
What is the current market cap of Advanced Medical Solutions Group?Advanced Medical Solutions Group's current market cap is $636M.
What is the current revenue of Advanced Medical Solutions Group?Advanced Medical Solutions Group's last 12 months revenue is $316M.
What is the current revenue growth of Advanced Medical Solutions Group?Advanced Medical Solutions Group revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Advanced Medical Solutions Group?Current revenue multiple of Advanced Medical Solutions Group is 2.3x.
What is the current EBITDA of Advanced Medical Solutions Group?Advanced Medical Solutions Group's last 12 months EBITDA is $70M.
What is Advanced Medical Solutions Group's EBITDA margin?Advanced Medical Solutions Group's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Advanced Medical Solutions Group?Current EBITDA multiple of Advanced Medical Solutions Group is 10.3x.
What is the current FCF of Advanced Medical Solutions Group?Advanced Medical Solutions Group's last 12 months FCF is $23M.
What is Advanced Medical Solutions Group's FCF margin?Advanced Medical Solutions Group's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Advanced Medical Solutions Group?Current FCF multiple of Advanced Medical Solutions Group is 31.7x.
How many companies Advanced Medical Solutions Group has acquired to date?As of June 2026, Advanced Medical Solutions Group has acquired 3 companies.
What was the largest acquisition by Advanced Medical Solutions Group?$154M acquisition of Péters Surgical on 13th March 2024 was the largest M&A Advanced Medical Solutions Group has done to date.
What companies Advanced Medical Solutions Group acquired?Advanced Medical Solutions Group acquired Péters Surgical, Raleigh Coatings, and Sealantis.
In how many companies Advanced Medical Solutions Group has invested to date?Advanced Medical Solutions Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Advanced Medical Solutions Group

Lists including Advanced Medical Solutions Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial